BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gong YH, Sun LP, Jin SG, Yuan Y. Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7,241 subjects from China. Eur J Clin Microbiol Infect Dis. 2010;29:907-911. [PMID: 20440530 DOI: 10.1007/s10096-010-0944-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Xu Q, Wu YF, Li Y, He CY, Sun LP, Liu JW, Yuan Y. SNP-SNP interactions of three new pri-miRNAs with the target gene PGC and multidimensional analysis of H. pylori in the gastric cancer/atrophic gastritis risk in a Chinese population. Oncotarget. 2016;7:23700-23714. [PMID: 26988755 DOI: 10.18632/oncotarget.8057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
2 Piao Y, Li Y, Xu Q, Liu JW, Xing CZ, Xie XD, Yuan Y. Association of MTOR and AKT Gene Polymorphisms with Susceptibility and Survival of Gastric Cancer. PLoS One 2015;10:e0136447. [PMID: 26317520 DOI: 10.1371/journal.pone.0136447] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
3 Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Yuan Y. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers. Scand J Gastroenterol. 2014;49:259-266. [PMID: 24329006 DOI: 10.3109/00365521.2013.869352] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
4 McNulty CA, Lehours P, Mégraud F. Diagnosis of Helicobacter pylori Infection. Helicobacter. 2011;16 Suppl 1:10-18. [PMID: 21896080 DOI: 10.1111/j.1523-5378.2011.00875.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
5 Xu Q, Chen MY, He CY, Sun LP, Yuan Y. Promoter polymorphisms in trefoil factor 2 and trefoil factor 3 genes and susceptibility to gastric cancer and atrophic gastritis among Chinese population. Gene. 2013;529:104-112. [PMID: 23933418 DOI: 10.1016/j.gene.2013.07.070] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
6 Gong Y, He C, Duan Z, Sun L, Xu Q, Xing C, Yuan Y. Association of two ERCC4 tagSNPs with susceptibility to atrophic gastritis and gastric cancer in Chinese. Gene. 2013;519:335-342. [PMID: 23415627 DOI: 10.1016/j.gene.2013.01.059] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
7 Xu Q, Chen TJ, He CY, Sun LP, Liu JW, Yuan Y. MiR-27a rs895819 is involved in increased atrophic gastritis risk, improved gastric cancer prognosis and negative interaction with Helicobacter pylori. Sci Rep 2017;7:41307. [PMID: 28150722 DOI: 10.1038/srep41307] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
8 Xu Q, Dong Q, He C, Liu W, Sun L, Liu J, Xing C, Li X, Wang B, Yuan Y. A new polymorphism biomarker rs629367 associated with increased risk and poor survival of gastric cancer in chinese by up-regulated miRNA-let-7a expression. PLoS One. 2014;9:e95249. [PMID: 24760009 DOI: 10.1371/journal.pone.0095249] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
9 Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011;16 Suppl 1:1-9. [PMID: 21896079 DOI: 10.1111/j.1523-5378.2011.00874] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Xu Q, Dong QG, Sun LP, He CY, Yuan Y. Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study. BMC Clin Pathol. 2013;13:11. [PMID: 23521833 DOI: 10.1186/1472-6890-13-11] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
11 Guo F, Xu Q, Lv Z, Ding HX, Sun LP, Zheng ZD, Yuan Y. Correlation Between TNFAIP2 Gene Polymorphism and Prediction/Prognosis for Gastric Cancer and Its Effect on TNFAIP2 Protein Expression. Front Oncol 2020;10:1127. [PMID: 32793480 DOI: 10.3389/fonc.2020.01127] [Reference Citation Analysis]
12 Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35:469-476. [PMID: 22221289 DOI: 10.1111/j.1365-2036.2011.04969.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
13 Liu S, Liu JW, Sun LP, Gong YH, Xu Q, Jing JJ, Yuan Y. Association of IL10 gene promoter polymorphisms with risks of gastric cancer and atrophic gastritis. J Int Med Res. 2018;46:5155-5166. [PMID: 30205739 DOI: 10.1177/0300060518792785] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
14 Shah A, Talley NJ, Walker M, Koloski N, Morrison M, Burger D, Andrews JM, Mcguckin M, Jones M, Holtmann G. Is There a Link Between H. Pylori and the Epidemiology of Crohn’s Disease? Dig Dis Sci 2017;62:2472-80. [DOI: 10.1007/s10620-017-4496-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
15 Zou D, Xu L, Li H, Ma Y, Gong Y, Guo T, Jing Z, Xu X, Zhang Y. Role of abnormal microRNA expression in Helicobacter pylori associated gastric cancer. Crit Rev Microbiol 2019;45:239-51. [PMID: 30776938 DOI: 10.1080/1040841X.2019.1575793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Best LM, Takwoingi Y, Siddique S, Selladurai A, Gandhi A, Low B, Yaghoobi M, Gurusamy KS. Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database Syst Rev. 2018;3:CD012080. [PMID: 29543326 DOI: 10.1002/14651858.cd012080.pub2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
17 Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011;16:1-9. [PMID: 21896079 DOI: 10.1111/j.1523-5378.2011.00874.x] [Cited by in Crossref: 172] [Cited by in F6Publishing: 174] [Article Influence: 15.6] [Reference Citation Analysis]
18 Jing JJ, Sun LP, Xu Q, Yuan Y. Effect of ERCC8 tagSNPs and their association with H. pylori infection, smoking, and alcohol consumption on gastric cancer and atrophic gastritis risk. Tumour Biol 2015;36:9525-35. [PMID: 26130415 DOI: 10.1007/s13277-015-3703-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
19 Meng X, Wang Q, He C, Chen M, Liu J, Liu W, Yuan Y. An inverse association of Helicobacter pylori infection with oral squamous cell carcinoma. J Oral Pathol Med 2016;45:17-22. [PMID: 25899621 DOI: 10.1111/jop.12324] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Wang BG, Ding HX, Lv Z, Xu Q, Yuan Y. Interaction of HULC polymorphisms with Helicobacter pylori infection plays a strong role for the prediction of gastric cancer risk. Future Oncol 2020;16:1997-2006. [PMID: 32941073 DOI: 10.2217/fon-2020-0228] [Reference Citation Analysis]
21 Wu YF, Xu Q, He CY, Li Y, Liu JW, Deng N, Sun LP, Yuan Y. Association of Polymorphisms in three pri-miRNAs that Target Pepsinogen C with the Risk and Prognosis of Gastric Cancer. Sci Rep 2017;7:39528. [PMID: 28067243 DOI: 10.1038/srep39528] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
22 Duan Z, He C, Gong Y, Li P, Xu Q, Sun LP, Wang Z, Xing C, Yuan Y. Promoter polymorphisms in DNA repair gene ERCC5 and susceptibility to gastric cancer in Chinese. Gene. 2012;511:274-279. [PMID: 22982416 DOI: 10.1016/j.gene.2012.09.025] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
23 Li P, He C, Sun L, Dong N, Yuan Y. Pepsinogen I and II expressions in situ and their correlations with serum pesignogen levels in gastric cancer and its precancerous disease. BMC Clin Pathol. 2013;13:22. [PMID: 24004680 DOI: 10.1186/1472-6890-13-22] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
24 Kayali S, Gaiani F, Manfredi M, Minelli R, Nervi G, Nouvenne A, Leandro G, Di Mario F, De' Angelis GL. Inverse association between Helicobacter pylori and inflammatory bowel disease: myth or fact? Acta Biomed 2018;89:81-6. [PMID: 30561399 DOI: 10.23750/abm.v89i9-S.7878] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Xu Q, Liu JW, He CY, Sun LP, Gong YH, Jing JJ, Xing CZ, Yuan Y. The interaction effects of pri-let-7a-1 rs10739971 with PGC and ERCC6 gene polymorphisms in gastric cancer and atrophic gastritis. PLoS One. 2014;9:e89203. [PMID: 24586594 DOI: 10.1371/journal.pone.0089203] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
26 Chung HA, Lee SY, Moon HW, Kim JH, Sung IK, Park HS, Shim CS, Han HS. Does the antibody production ability affect the serum anti-Helicobacter pylori IgG titer? World J Gastrointest Pathophysiol 2016; 7(3): 288-295 [PMID: 27574567 DOI: 10.4291/wjgp.v7.i3.288] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
27 Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei WQ, Qiao YL, Inoue M. Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol 2011; 17(39): 4421-4428 [PMID: 22110269 DOI: 10.3748/wjg.v17.i39.4421] [Cited by in CrossRef: 112] [Cited by in F6Publishing: 120] [Article Influence: 10.2] [Reference Citation Analysis]
28 Jing JJ, Lu YZ, Sun LP, Liu JW, Gong YH, Xu Q, Dong NN, Yuan Y. Epistatic SNP interaction of ERCC6 with ERCC8 and their joint protein expression contribute to gastric cancer/atrophic gastritis risk. Oncotarget 2017;8:43140-52. [PMID: 28562347 DOI: 10.18632/oncotarget.17814] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]